Aurobindo Pharma surges on receiving USFDA nod for Montelukast Sodium and Chewable tablets

06 Aug 2012 Evaluate

Aurobindo Pharma is currently trading at Rs. 114.50, up by 1.05 points or 0.93% from its previous closing of Rs. 113.45 on the BSE.

The scrip opened at Rs. 114.00 and has touched a high and low of Rs. 115.00 and Rs. 112.55 respectively. So far 72302 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 163.60 on 05-Aug-2011 and a 52 week low of Rs. 80.35 on 18-Nov-2011.

Last one week high and low of the scrip stood at Rs. 115.35 and Rs. 100.35 respectively. The current market cap of the company is Rs. 3344.98 crore.

The promoters holding in the company stood at 54.76% while Institutions and Non-Institutions held 30.34% and 14.91% respectively.  

Aurobindo Pharma has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Montelukast Sodium tablets 10mg (ANDA 202468) and Montelukast Sodium Chewable tablets 4mg and 5mg (ANDA 202096). The products are ready for a first-day launch.

Montelukast Sodium tablets 10mg and Chewable tablets 4mg and 5mg are the generic equivalent of Merck & Company Inc’s Singulair tablets 10mg and Chewable tablets 4mg and 5mg respectively. Montelukast Sodium is indicated for Prophylaxis and chronic treatment of asthma in adults and pediatric patients 12 months of age and older.

According to IMS, the annual sales of Montelukast Sodium tablets 10mg is approximately $3.5 billion and that of Montelukast Sodium Chewable tablets is $1.1 billion for the twelve months ending March 2012.

The products have been approved out of Unit VII (SEZ) formulations facility in Hyderabad, India. The company now has a total of 157 ANDA approvals (131 final approvals including 1 from Aurolife Pharma LLC and 26 tentative approvals from USFDA.

Aurobindo Pharma has a product presence in key therapeutic segments like SSPs, cephalosporins, antivirals, CNS, cardio-vascular, gastroenterology, etc. The company is the market leader in semi-synthetic penicillin drugs.

Aurobindo Pharma Share Price

1193.70 21.20 (1.81%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×